The Global Implantable Infusion Pumps Market is poised to grow at a CAGR of around 6.3% over the next decade to reach approximately $14.33 billion by 2025.
Some of the prominent trends that the market is Chemotherapy for cancer patients, Surge for near-physiologic programmable method of insulin delivery, Increase in device based drug delivery technologies and Growth Opportunities/Investment Opportunities.
Based on Application the market is categorized into Cancer Treatment, Spasticity, Analgesia and Diabetes Mellitus. The Cancer Treatment segment is further divided as Cancer Pain, Noncancer Pain, Mixed Sarcoma and Skin Cancers and Gastric Cancer.
This industry report analyzes the global markets for Implantable Infusion Pumps across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Chemotherapy for cancer patients
3.1.2 Surge for near-physiologic programmable method of insulin delivery
3.1.3 Increase in device based drug delivery technologies
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
4 Implantable Infusion Pumps Market, By Application
4.1 Cancer Treatment
22.214.171.124 Cancer Pain
126.96.36.199 Noncancer Pain
188.8.131.52 Mixed Sarcoma and Skin Cancers
184.108.40.206 Gastric Cancer
4.4 Diabetes Mellitus
5 Implantable Infusion Pumps Market, By Geography
6 Key Player Activities
6.1 Acquisitions & Mergers
6.2 Agreements, Partnerships, Collaborations and Joint Ventures
6.3 Product Launch & Expansions
6.4 Other Activities
7 Leading Companies
7.1 Alnylam Pharmaceuticals, Inc.
7.2 Debiotech S.A.
7.3 Delpor, Inc.
7.4 Eksigent Technologies, LLC
7.5 Eli Lilly and Company
7.6 Flowonix Medical, Inc.
7.7 FluidSynchrony, LLC
7.8 Intarcia Therapeutics, Inc.
7.9 Medallion Therapeutics, Inc.
7.10 Nano Precision Medical
7.11 Pharmaco-Kinesis Corporation
7.12 University of Southern California Company
7.13 Halyard Health
7.14 Codman & Shurtleff
For more information about this report visit http://www.researchandmarkets.com/research/zql7b4/implantable
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-implantable-infusion-pumps-market-2016-2025-1433-billion-growth-opportunitiesinvestment-opportunities---research-and-markets-300398019.html
SOURCE Research and Markets